论文部分内容阅读
静脉滴注阿昔洛韦治疗慢性乙型肝炎患者３１例（男性２１例，女性１０例；年龄３３±ｓ６ａ），７５０ｍｇ，ｑｄ，共１ｍｏ。另２０例（男性１８例，女性２例；年龄３５±７ａ），口服垂盆草冲剂为对照，１０ｇ，ｔｉｄ，共１ｍｏ。结果：ＨＢｅＡｇ阴转率，前者为４５％，后者为０（Ｐ＜０．０１）；ＡＬＴ复常率，前者为７９％，后者为７０％（Ｐ＞０．０５）。
31 cases of chronic hepatitis B were treated with intravenous injection of acyclovir (21 males and 10 females; age 33 ± s6a), 750 mg qd for 1 month. The other 20 cases (18 males, 2 females; age 35 ± 7a), oral Sedum herbs as a control, 10g, tid, a total of 1mo. Results: The negative rate of HBeAg was 45% in the former and 0 in the latter (P <0.01). The recovery rate of ALT was 79% in the former and 70% in the latter (P> 0.05).